Chronic lymphocytic leukemia (CLL) is a hematologic malignancy characterized by the clonal expansion of abnormal B lymphocytes. 1 Despite significant advancements in targeted therapies like Bruton’s ...

ATTR-PN diagnosis requires a combination of neurological and non-neurological tests, such as blood pressure monitoring, a ...

The most important goal of patients with generalized myasthenia gravis and their caregivers was to achieve stable disease. Patients with generalized myasthenia gravis (gMG) still have many unmet needs ...

Patients treated with combined low-dose rituximab regimen had better improvements and a higher proportion of favorable response in scale assessments at each follow-up visit. A simplified regimen of ...

There was no statistically significant association between the concentration of vatiquinone and Fridericia corrected QT interval. A supratherapeutic dose of 1400 mg of vatiquinone is safe and ...

This case report corresponds with others suggesting that tobacco use and asbestos exposure may be associated with the pathophysiology of IgG4-RD. An elderly male patient with a history of smoking and ...

Investigators found that prior to the exchange transfusion procedure, neonates with ABO blood group incompatibility had higher levels of serum total bilirubin and serum indirect bilirubin, and higher ...

Leukemia cutis represents a rare cutaneous manifestation arising from the infiltration of leukemic cells into the skin. A rare case of leukemia cutis (LC) appearing in a patient with primary ...

Obeticholic acid, seladelpar, and elafibranor all significantly increased the biochemical response rate. Elafibranor seems to be slightly more effective than seladelpar as a second-line therapy in ...

Hashimoto thyroiditis demonstrated a significant causal relationship with microscopic polyangiitis (MPA) in Mendelian randomization analysis. A significant causal association between Hashimoto ...

Anti-CD19 CAR-T therapy demonstrated sustained B-cell depletion and reduced fibrosis-associated T-helper cells in a murine model of IgG4-RD. Anti-CD19 chimeric antigen receptor T-cell (CAR-T) therapy ...